Digital follow‐up by means of dermatoscopy and reflectance confocal microscopy of actinic keratosis treated with Imiquimod 3.75% cream

Background Imiquimod 3.75% cream (Zyclara® Meda, Stockholm, Sweden) is a new field‐directed therapy for actinic keratosis (AK). Objectives The aim is to evaluate efficacy and the morphologic dynamic changes induced by this treatment by means of dermatoscopy and reflectance confocal microscopy (RCM)...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2020-07, Vol.34 (7), p.1471-1477
Hauptverfasser:	Benati, E., Longhitano, S., Pampena, R., Mirra, M., Raucci, M., Pellacani, G., Longo, C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aminoquinolines - therapeutic use Dermoscopy Follow-Up Studies Humans Imiquimod Keratosis, Actinic - diagnostic imaging Keratosis, Actinic - drug therapy Microscopy, Confocal Sweden Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!